Public Sector Pension Investment Board United Therapeutics Corp Transaction History

Public Sector Pension Investment Board

8 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2023 May 12, 2023	SELL	$212.99 - $276.17 $1.7 Million - $2.21 Million	-8,000 Reduced 50.0%	8,000 $1.79 Million
Q4 2022 Feb 14, 2023	BUY	$205.95 - $280.43 $3.3 Million - $4.49 Million	16,000 New	16,000 $4.45 Million
Q3 2020 Nov 13, 2020	SELL	$99.9 - $121.13 $930,668 - $1.13 Million	-9,316 Closed	0 $0
Q2 2020 Aug 14, 2020	BUY	$92.74 - $125.82 $863,965 - $1.17 Million	9,316 New	9,316 $1.13 Million
Q1 2020 May 14, 2020	SELL	$79.39 - $115.35 $1.6 Million - $2.32 Million	-20,156 Closed	0 $0
Q4 2019 Feb 14, 2020	BUY	$78.31 - $95.34 $1.58 Million - $1.92 Million	20,156 New	20,156 $1.78 Million
Q1 2019 May 14, 2019	SELL	$107.15 - $126.84 $1.99 Million - $2.36 Million	-18,600 Closed	0 $0
Q4 2018 Feb 14, 2019	BUY	$101.4 - $128.73 $1.89 Million - $2.39 Million	18,600 New	18,600 $2.03 Million

668

42.8M

194K

295K

Ticker UTHR
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 45,516,300
Market Cap $16.6B
Description
United Therapeutics Corporation, a biotechnology company, engages in the development and commercialization of products to address the unmet medical needs of patients with chronic and life-threatening diseases in the United States and internationally. Its commercial therapies include Remodulin to treat patients with pulmonary arterial hypertensio...

Get notified when there are updates to the investment portfolio of Public Sector Pension Investment Board, based on Form 13F filings with the SEC.

Stay updated on Public Sector Pension Investment Board with notifications on news.